Pig Kidney Transplant Research: What It Could Mean for Kidney Patients

Laboratory research exploring pig kidney transplant alternatives for kidney patients

For many people living with kidney disease, the possibility of needing a transplant can feel daunting. Long waiting lists, regular hospital appointments and the ongoing demands of dialysis place a heavy burden on both physical health and emotional wellbeing. While a kidney transplant is often described as a fresh start, the reality is that many […]

Could Lab-Grown “Bodyoids” Change the Future for Kidney Patients?

Scientists have successfully grown “bodyoids” — collections of human organs in the lab — which could one day lead to transplantable kidneys without the need for a human donor. MRIKPA explains what this research means for kidney patients and why it offers cautious but real hope for the future.

How MRIKPA members are enjoying the Spring weather

Embracing Life with Renal Health Challenges: Support & Inspiration from MRIKPA As members of the Manchester Royal Infirmary Kidney Patients’ Association (MRIKPA), we understand the unique challenges of living with Chronic Kidney Disease (CKD). Whether you’re a patient, carer, or simply looking for kidney health information, our mission is to support, empower, and inspire you. […]

The MRI – A Lifeline for CKD Patients

Renal Care at Manchester Royal Infirmary Living with Chronic Kidney Disease (CKD) presents daily challenges, but for patients at Manchester Royal Infirmary (MRI), expert care and a strong support network provide reassurance and hope. As a patient-run organisation, MRIKPA understands the struggles of CKD first-hand, and we are committed to ensuring that Kidney patients know […]

NICE Rejects Sparsentan for IgA Nephropathy: What It Means for Kidney Patients

Kidney Advocacy Groups Disappointed by Draft NICE Decision A recent draft decision by the National Institute for Health and Care Excellence (NICE) has caused frustration among kidney patients and advocacy groups. On March 4, 2025, NICE announced that it would not approve Sparsentan, a promising new treatment for IgA nephropathy (IgAN), for NHS funding at […]